|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Revance Therapeutics, Inc. (RVNC) |
|
|
$3.65 0.00 (0.00%) as of 4:30 Wed 2/5
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
32 |
|
|
|
Total
Direct Shares :
|
872,320 |
|
|
Total
Indirect Shares :
|
15,198,604 |
| |
%
Held by Insiders:
|
1.06% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Gangolli Julian S |
|
2025-02-06 |
0 |
2017-05-11 |
0 |
| Beraud Jill |
|
2025-02-06 |
0 |
2019-06-04 |
0 |
| Coric Vlad |
|
2025-02-06 |
0 |
2023-03-01 |
0 |
| Moxie Dwight |
|
2025-02-06 |
0 |
2020-02-18 |
0 |
| Russell Angus C. |
|
2025-02-06 |
0 |
2017-05-11 |
0 |
| Schilke Tobin |
|
2025-02-06 |
0 |
2018-11-05 |
0 |
| Ware Olivia C |
|
2025-02-06 |
0 |
2021-03-08 |
0 |
| Foley Mark J |
|
2025-02-06 |
0 |
2025-02-04 |
0 |
| Hollander David |
|
2025-02-06 |
0 |
|
0 |
| Kolaja Carey Oconnor |
|
2025-02-06 |
0 |
2021-03-01 |
0 |
| Nolet Chris |
|
2025-02-06 |
0 |
2019-07-16 |
0 |
| Jordan Erica |
|
2025-02-06 |
0 |
|
0 |
| Sjuts Dustin S |
President |
2024-03-18 |
167,550 |
|
0 |
| Rankin Aubrey |
Director |
2022-03-15 |
94,091 |
2022-03-15 |
475,913 |
| Joshi Abhay |
COO, President of R&D |
2022-03-15 |
120,708 |
2015-12-14 |
0 |
| Vickers Philip J. |
Director |
2021-05-05 |
23,663 |
2017-05-11 |
0 |
| Byrnes Robert F |
Director |
2020-05-14 |
16,500 |
2020-05-14 |
13,665 |
| Gardner Phyllis |
Director |
2020-05-14 |
16,500 |
2014-02-11 |
457,085 |
| Mcdowell Caryn Gordon |
SVP, GC & Secretary |
2020-02-15 |
23,453 |
2018-05-01 |
0 |
| Browne L Daniel |
CEO and President, Director |
2019-06-28 |
152,193 |
2019-06-28 |
409 |
| Allouche Cyril |
Principal Accounting Officer |
2019-03-18 |
6,400 |
2018-06-20 |
0 |
| Zavodnick Todd Erik |
CCO & President, |
2018-10-15 |
96,407 |
2017-09-18 |
0 |
| Silvernail Lauren P |
CFO & CBO |
2018-05-22 |
65,497 |
2014-05-19 |
0 |
| Eastman Ronald W |
Director, 10% Owner |
2017-05-11 |
3,000 |
2017-05-11 |
4,134,962 |
| Ruegg Curtis |
EVP, Technical Operations |
2016-06-13 |
23,944 |
|
0 |
| Bertolino Arthur Peter |
EVP and Chief Medical Officer |
2015-11-17 |
34,001 |
2014-09-02 |
0 |
| Waugh Jacob |
Chief Scientific Officer |
2015-05-19 |
28,413 |
|
0 |
| Glasheen James Walter |
Director |
2014-02-11 |
0 |
2014-02-11 |
709,162 |
| Tunnicliffe Jonathan |
Director, 10% Owner |
2014-02-11 |
0 |
2014-02-11 |
3,096,650 |
| Essex Woodlands Health Ventures Fund Viii-B Lp |
10% Owner |
2014-02-11 |
0 |
2014-02-11 |
117,458 |
| Nq Hcif Gp, Ltd. |
10% Owner |
2014-02-11 |
0 |
2014-02-11 |
3,096,650 |
| Wooten Ronald J |
Director, 10% Owner |
2014-02-11 |
0 |
2014-02-11 |
3,096,650 |
|
|
